Array comparative genomic hybridization analysis of adult acute leukemia patients

Cancer Genetics and Cytogenetics

Volumn 197, Issue 2, 2010, Pages 122-129

  Yasar, Duygu ^a   Karadogan, Ihsan ^a   Alanoglu, Guchan ^b   Akkaya, Bahar ^a   Luleci, Guven ^a   Salim, Ozan ^a   Timuragaoglu, Aysen ^a   Toruner, Gokce A ^c   Berker Karauzum, Sibel ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2B; NOTCH1 RECEPTOR; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA1 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; TRANSCRIPTION FACTOR HOXA9; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; BASE PAIRING; CANCER RECURRENCE; CANCER RELAPSE; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DUPLICATION; CHROMOSOME LOSS; CHROMOSOME NUMBER; CHROMOSOME TRANSLOCATION; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENOMIC INSTABILITY; HUMAN; MALE; MONOSOMY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRISOMY; X CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; CHROMOSOME ABERRATIONS; COMPARATIVE GENOMIC HYBRIDIZATION; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77249168761     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.018     Document Type: Article

References (21)

1. Graux C., Stevens-Kroef M., Lafage M., Dastugue N., Harrison C.J., Mugneret F., Bahloula K., Struski S., Gregoire M.J., Nadal N., Lippert E., Taviaux S., Simons A., Kuiper R.P., Moorman A.V., Barber K., Bosly A., Michaux L., Vandenberghe P., Lahortiga I., De Keersmaecker K., Wlodarska I., Cools J., Hagemeijer A., and Poirel H.A. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia. Leukemia 23 (2009) 125-133
2. Van Dongen J.J., Macintyre E.A., Gabert J.A., Delabesse E., Rossi V., Saglio G., Gottardi E., Rambaldi A., Dotti G., Griesinger F., Parreira A., Gameiro P., Diaz M.G., Malec M., Langerak A.W., San Miguel J.F., and Biondi A. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia 13 (1999) 1901-1928
3. Calasanz M.J., and Cigudosa J.C. Molecular cytogenetics in translational oncology: when chromosomes meet genomics. Clin Transl Oncol 10 (2008) 20-29
4. Kearney L., and Horsley S.W. Molecular cytogenetics in haematological malignancy: current technology and future prospects. Chromosoma 114 (2005) 286-294
5. Evers C., Beier M., Poelitz A., Hildebrandt B., Servan K., Drechsler M., Germing U., Royer H.D., and Royer-Pokora B. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH. Genes Chromosomes Cancer 46 (2007) 1119-1128
6. Martinez-Ramirez A., Urioste M., Melchor L., Blesa D., Valle L., de Andres S.A., Kok K., Calasanz M.J., Cigudosa J.C., and Benitez J. Analysis of myelodysplastic syndromes with complex karyotypes by high-resolution comparative genomic hybridization and subtelomeric CGH array. Genes Chromosomes Cancer 42 (2005) 287-298
7. Tyybakinoja A., Elonen E., Piippo K., Porkka K., and Knuutila S. Oligonucleotide array-CGH reveals cryptic gene copy number alterations in karyotypically normal acute myeloid leukemia. Leukemia 21 (2007) 571-574
8. Van Vlierberghe P., Meijerink J.P.P., Lee C., Ferrando A.A., Look A.T., Wering E.R.V., Beverloo H.B., Aster J.C., and Pieters R. A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia. Leukemia 20 (2006) 1245-1253
9. Shaffer L.G., Slovak M.L., and Campbell L.J. ISCN: An International System for Human Cytogenetic Nomenclature (2009), S. Karger, Basel
10. Paulsson K., Cazier J.B., Macdougall F., Stevens J., Stasevich I., Vrcelj N., Chaplin T., Lillington D.M., Lister T.A., and Young B.D. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: unexpected similarities with pediatric disease. Proc Natl Acad Sci USA 105 (2008) 6708-6713
11. Schoumans J., Johansson B., Corcoran M., Kuchinskaya E., Golovleva I., Grander D., Forestier E., Staaf J., Borg A., Gustafsson B., Blennow E., and Nordgren A. Characterisation of dic(9;20)(p11-13;q11) in childhood B-cell precursor acute lymphoblastic leukaemia by tiling resolution array-based comparative genomic hybridisation reveals clustered breakpoints at 9p13.2 and 20q11.2. Br J Haematol 135 (2006) 492-499
12. Davidsson J., Andersson A., Paulsson K., Heidenblad M., Isaksson M., Borg A., Heldrup J., Behrendtz M., Panagopoulos I., Fioretos T., and Johansson B. Tiling resolution array comparative genomic hybridization, expression and methylation analyses of dup(1q) in Burkitt lymphomas and pediatric high hyperdiploid acute lymphoblastic leukemias reveal clustered near-centromeric breakpoints and overexpression of genes in 1q22-32.3. Hum Mol Genet 16 (2007) 2215-2225
13. Kuiper R.P., Schoenmakers E.F., van Reijmersdal S.V., Hehir-Kwa J.Y., van Kessel A.G., van Leeuwen F.N., and Hoogerbrugge P.M. High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression. Leukemia 21 (2007) 1258-1266
14. O'Neil J., and Look A.T. Mechanisms of transcription factor deregulation in lymphoid cell transformation. Oncogene 26 (2007) 6838-6849
15. Downing J.R., and Mullighan C.G. Tumor-specific genetic lesions and their influence on therapy in pediatric acute lymphoblastic leukemia. Hematol Am Soc Hematol Educ Program 118-22 (2006) 508
16. Usvasalo A., Savola S., Raty R., Vettenranta K., Harila-Saari A., Koistinen P., Savolainen E.R., Elonen E., Saarinen-Pihkala U.M., and Knuutila S. CDKN2A deletions in acute lymphoblastic leukemia of adolescents and young adults: an array CGH study. Leuk Res 32 (2008) 1228-1235
17. Cohen-Armon M. PARP-1 activation in the ERK signaling pathway. Trends Pharmacol Sci 28 (2007) 556-560
18. De Alvaro C., Nieto-Vazquez I., Rojas J.M., and Lorenzo M. Nuclear exclusion of forkhead box O and Elk1 and activation of nuclear factor-kappaB are required for C2C12-RasV12C40 myoblast differentiation. Endocrinology 149 (2008) 793-801
19. Gregorj C., Ricciardi M.R., Petrucci M.T., Scerpa M.C., De Cave F., Fazi P., Vignetti M., Vitale A., Mancini M., Cimino G., Palmieri S., Di Raimondo F., Specchia G., Fabbiano F., Cantore N., Mosna F., Camera A., Luppi M., Annino L., Miraglia E., Fioritoni G., Ronco F., Meloni G., Mandelli F., Andreeff M., Milella M., Foa R., and Tafuri A. ERK1/2 phosphorylation is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemia. Blood 109 (2007) 5473-5476
20. Gade P., Roy S.K., Li H., Nallar S.C., and Kalvakolanu D.V. Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1. Mol Cell Biol 28 (2008) 2528-2548
21. Akasaka T., Balasas T., Russell L.J., Sugimoto K.J., Majid A., Walewska R., Karran E.L., Brown D.G., Cain K., Harder L., Gesk S., Martin-Subero J.I., Atherton M.G., Bruggemann M., Calasanz M.J., Davies T., Haas O.A., Hagemeijer A., Kempski H., Lessard M., Lillington D.M., Moore S., Nguyen-Khac F., Radford-Weiss I., Schoch C., Struski S., Talley P., Welham M.J., Worley H., Strefford J.C., Harrison C.J., Siebert R., and Dyer M.J. Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood 109 (2007) 3451-3461